Literature DB >> 28111021

Structure of the Full-length VEGFR-1 Extracellular Domain in Complex with VEGF-A.

Sandra Markovic-Mueller1, Edward Stuttfeld2, Mayanka Asthana1, Tobias Weinert1, Spencer Bliven3, Kenneth N Goldie4, Kaisa Kisko1, Guido Capitani1, Kurt Ballmer-Hofer5.   

Abstract

Vascular endothelial growth factors (VEGFs) regulate blood and lymph vessel development upon activation of three receptor tyrosine kinases: VEGFR-1, -2, and -3. Partial structures of VEGFR/VEGF complexes based on single-particle electron microscopy, small-angle X-ray scattering, and X-ray crystallography revealed the location of VEGF binding and domain arrangement of individual receptor subdomains. Here, we describe the structure of the full-length VEGFR-1 extracellular domain in complex with VEGF-A at 4 Å resolution. We combined X-ray crystallography, single-particle electron microscopy, and molecular modeling for structure determination and validation. The structure reveals the molecular details of ligand-induced receptor dimerization, in particular of homotypic receptor interactions in immunoglobulin homology domains 4, 5, and 7. Functional analyses of ligand binding and receptor activation confirm the relevance of these homotypic contacts and identify them as potential therapeutic sites to allosterically inhibit VEGFR-1 activity.
Copyright © 2017 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  VEGF receptor; X-ray crystallography; angiogenesis; extracellular domain; receptor tyrosine kinase; single-particle negative stain electron microscopy; small-angle X-ray scattering; vascular endothelial growth factor

Mesh:

Substances:

Year:  2017        PMID: 28111021     DOI: 10.1016/j.str.2016.12.012

Source DB:  PubMed          Journal:  Structure        ISSN: 0969-2126            Impact factor:   5.006


  24 in total

1.  Cooperative interactions between VEGFR2 extracellular Ig-like subdomains ensure VEGFR2 dimerization.

Authors:  Christopher King; Daniel Wirth; Samuel Workman; Kalina Hristova
Journal:  Biochim Biophys Acta Gen Subj       Date:  2017-08-25       Impact factor: 3.770

2.  Histone H3.3G34-Mutant Interneuron Progenitors Co-opt PDGFRA for Gliomagenesis.

Authors:  Carol C L Chen; Shriya Deshmukh; Selin Jessa; Djihad Hadjadj; Véronique Lisi; Augusto Faria Andrade; Damien Faury; Wajih Jawhar; Rola Dali; Hiromichi Suzuki; Manav Pathania; Deli A; Frank Dubois; Eleanor Woodward; Steven Hébert; Marie Coutelier; Jason Karamchandani; Steffen Albrecht; Sebastian Brandner; Nicolas De Jay; Tenzin Gayden; Andrea Bajic; Ashot S Harutyunyan; Dylan M Marchione; Leonie G Mikael; Nikoleta Juretic; Michele Zeinieh; Caterina Russo; Nicola Maestro; Angelia V Bassenden; Peter Hauser; József Virga; Laszlo Bognar; Almos Klekner; Michal Zapotocky; Ales Vicha; Lenka Krskova; Katerina Vanova; Josef Zamecnik; David Sumerauer; Paul G Ekert; David S Ziegler; Benjamin Ellezam; Mariella G Filbin; Mathieu Blanchette; Jordan R Hansford; Dong-Anh Khuong-Quang; Albert M Berghuis; Alexander G Weil; Benjamin A Garcia; Livia Garzia; Stephen C Mack; Rameen Beroukhim; Keith L Ligon; Michael D Taylor; Pratiti Bandopadhayay; Christoph Kramm; Stefan M Pfister; Andrey Korshunov; Dominik Sturm; David T W Jones; Paolo Salomoni; Claudia L Kleinman; Nada Jabado
Journal:  Cell       Date:  2020-11-30       Impact factor: 41.582

Review 3.  Insulin and epidermal growth factor receptor family members share parallel activation mechanisms.

Authors:  Kathryn M Ferguson; Chun Hu; Mark A Lemmon
Journal:  Protein Sci       Date:  2020-04-28       Impact factor: 6.725

4.  Structure-Guided Molecular Engineering of a Vascular Endothelial Growth Factor Antagonist to Treat Retinal Diseases.

Authors:  Rakeeb Kureshi; Angela Zhu; Jikui Shen; Stephany Y Tzeng; Leilani R Astrab; Paul R Sargunas; Jordan J Green; Peter A Campochiaro; Jamie B Spangler
Journal:  Cell Mol Bioeng       Date:  2020-07-31       Impact factor: 2.321

5.  Heparin-binding VEGFR1 variants as long-acting VEGF inhibitors for treatment of intraocular neovascular disorders.

Authors:  Hong Xin; Nilima Biswas; Pin Li; Cuiling Zhong; Tamara C Chan; Eric Nudleman; Napoleone Ferrara
Journal:  Proc Natl Acad Sci U S A       Date:  2021-05-25       Impact factor: 11.205

Review 6.  Positive and Negative Regulation of Angiogenesis by Soluble Vascular Endothelial Growth Factor Receptor-1.

Authors:  Cristina M Failla; Miriam Carbo; Veronica Morea
Journal:  Int J Mol Sci       Date:  2018-04-27       Impact factor: 5.923

7.  Two-faced Fcab prevents polymerization with VEGF and reveals thermodynamics and the 2.15 Å crystal structure of the complex.

Authors:  Elisabeth Lobner; Anne-Sophie Humm; Georg Mlynek; Konstantin Kubinger; Michael Kitzmüller; Michael W Traxlmayr; Kristina Djinović-Carugo; Christian Obinger
Journal:  MAbs       Date:  2017-08-17       Impact factor: 5.857

8.  Structural basis of the activation of c-MET receptor.

Authors:  Emiko Uchikawa; Zhiming Chen; Guan-Yu Xiao; Xuewu Zhang; Xiao-Chen Bai
Journal:  Nat Commun       Date:  2021-07-01       Impact factor: 14.919

9.  Structure and function of vascular endothelial growth factor and its receptor system.

Authors:  Seong Ah Park; Mi Suk Jeong; Ki-Tae Ha; Se Bok Jang
Journal:  BMB Rep       Date:  2018-02       Impact factor: 4.778

Review 10.  Molecular Pharmacology of VEGF-A Isoforms: Binding and Signalling at VEGFR2.

Authors:  Chloe J Peach; Viviane W Mignone; Maria Augusta Arruda; Diana C Alcobia; Stephen J Hill; Laura E Kilpatrick; Jeanette Woolard
Journal:  Int J Mol Sci       Date:  2018-04-23       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.